FDA Approves RCC Drug, Prostate Cancer and Smoking Link: April News Roundup

Female AYA Cancer Survivors May Benefit From Increased Physical Activity

At baseline, 55% of patients achieved at least 6 metabolic equivalence tasks hours per week, 47% achieved it at timepoint 2, and 43% at timepoint 3.

Ariana Pelosci

Elevating the Quality of Cancer Care Via Cross-Department Collaboration

The study found that older females with central nervous system tumors had significantly lower vigorous physical activity participation vs their counterparts.

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Rachit Kumar, MD;Michael J. Pishvaian, MD, PhD;Nina D. Wagner-Johnston, MD;Valerie Lee, MD;Armine K. Smith, MD;Pouneh Razavi, MD;Curtiland Deville Jr., MD

April 7th 2025

Chemoimmunotherapy Elicits Survival Benefit in Older ES-SCLC Population

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Real-world data may support a new way to consider follow-up treatment for patients who are elderly with extensive-stage small cell lung cancer.

FDA OKs Larotrectinib in Adult and Pediatric NTRK+ Tumor Populations

Real-world data may support a new way to consider follow-up treatment for patients who are older with extensive-stage small cell lung cancer.

Data from the LOXO-TRK-14001, SCOUT, and NAVIGATE trials support the full approval of larotrectinib in NTRK gene fusion-positive tumors.

107 Neratinib-Based Combination Treatments for Patients With HER2-Positive Breast Cancer Brain Metastases

Data from the LOXO-TRK-14001, SCOUT, and NAVIGATE trials support the full approval of larotrectinib in NTRK gene fusion-positive tumors.

Related Content

Sarah Sammons;Rachel A. Freedman;Adam M. Brufsky;Ahmad Awada;Sara A. Hurvitz, MD;Nancy U. Lin, MD;Cristina Saura;Sheri Leung;Bethann S Hromatka

April 9th 2025

Female AYA Cancer Survivors May Benefit From Increased Physical Activity

Ariana Pelosci

Elevating the Quality of Cancer Care Via Cross-Department Collaboration

The study found that older females with central nervous system tumors had significantly lower vigorous physical activity participation vs their counterparts.

Rachit Kumar, MD;Michael J. Pishvaian, MD, PhD;Nina D. Wagner-Johnston, MD;Valerie Lee, MD;Armine K. Smith, MD;Pouneh Razavi, MD;Curtiland Deville Jr., MD

April 7th 2025

Chemoimmunotherapy Elicits Survival Benefit in Older ES-SCLC Population

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

FDA OKs Larotrectinib in Adult and Pediatric NTRK+ Tumor Populations

Real-world data may support a new way to consider follow-up treatment for patients who are older with extensive-stage small cell lung cancer.